FIELD: chemistry.
SUBSTANCE: invention relates to methods for producing 1-(4-methanesulfonyl-2-trifluoromethylbenzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridine-3-yl-acetic acid (Compound A). The first producing method consists in the interaction of a compound of the formula C9 with dimethyl ether of diazomalonic acid (DMDA) in the presence of a catalyst and an organic solvent to form a compound of the formula C10. Then, a reaction of the compound of the formula C10 with a strong base/acid is carried out to obtain the Compound A. The second synthesis method includes a reaction of the compound of the formula C9 with halogen to form a compound of the formula C11. The resulting compound of the formula C11 is subjected to interaction with dimethylmaleate to form the compound of the formula C10, which is converted into the Compound A by the above-mentioned method.
EFFECT: methods consist of a smaller number of stages, allow one to achieve higher yield of the product and have higher selectivity for the Compound A.
, , ,
18 cl, 1 dwg, 37 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF 2-ACETYLBENZO[h]QUINOLINE OBTAINING | 2012 |
|
RU2515990C2 |
METHOD OF PRODUCING 1a-METHYL-1a-(3'-THIOALKYLPROP-2'-YL)-1aH-1(9)a-homo(C-I)[5,6]FULLERENES | 2010 |
|
RU2459805C2 |
METHOD OF PRODUCING 3-ACETYLBENZO[f]QUINOLINE | 2014 |
|
RU2559360C1 |
METHOD OF PRODUCING 2,3,4,5-TETRAALKYLMAGNESACYCLOPENTA2,4-DIENES | 2010 |
|
RU2440354C1 |
1-PHENYL-2-PYRIDINYL ALKYL ALCOHOL DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | 2013 |
|
RU2655170C2 |
BICYCLIC COMPOUNDS, METHOD OF INHIBITION OF PLATELET ADHESION AND COMPOSITION FOR ITS REALIZATION | 1996 |
|
RU2169146C2 |
DERIVATIVES OF 1-PHENYL-2-PYRIDINYL-ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS | 2013 |
|
RU2637945C2 |
ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION | 1994 |
|
RU2149871C1 |
SURFACE-MODIFIED CALCIUM CARBONATE AS A CATALYST SUPPORT BASED ON TRANSITION METALS | 2017 |
|
RU2742335C2 |
METHODS FOR OBTAINING 5-[2-[7-(TRIFLUOROMETHYL)-5-[4-(TRIFLUOROMETHYL)PHENYL]PYRAZOLO[1,5-a]PYRIMIDINE-3-YL]ETHINYL]-2-PYRIDINAMINE | 2012 |
|
RU2630700C2 |
Authors
Dates
2021-10-01—Published
2018-03-29—Filed